Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Diabetes Textbook -

The Diabetes Textbook

Clinical Principles, Patient Management and Public Health Issues

Joel Rodriguez-Saldana (Herausgeber)

Media-Kombination
XI, 1178 Seiten | Ausstattung: Hardcover
2023 | 2nd ed. 2023
Springer International Publishing
978-3-031-25518-2 (ISBN)
CHF 299,55 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues (2nd Edition) addresses diabetes from a comprehensive, multidisciplinary perspective. Its purpose is to integrate state-of-the-art information on diabetes from specialists in various disciplines, including epidemiology, public health, pathophysiology, non-pharmacologic and pharmacologic treatment, patient support, acute and chronic complications, new and unproven therapies, and prevention.

The main benefit of "The Diabetes Textbook" is its integrative approach. The book is therefore intended for three main types of readers: 1) physicians and health professionals seeking a comprehensive approach to diabetes; 2) those with previous expertise in a specific professional area who want to expand their knowledge; and 3) those interested in learning about topics not previously covered, who will find the contents of "The Diabetes Textbook" both enriching and innovative.

The Diabetes Textbook is intended for a broad readership, including professors of medicine and related disciplines (nursing, nutrition, psychology); general physicians; internists and specialists, e.g. in ophthalmology, endocrinology, cardiology, obstetrics and gynecology, pediatrics, geriatrics, epidemiology and public health.

To address these readers' needs, the second edition is divided into the following eleven sections: 1) Magnitude of the Problem from an Individual and Social Context, 2) Diagnosis, Classification and Mechanisms of Disease, 3) Global Experiences in Diabetes Care, 4) Basic Components of Management: Patient-Centeredness, Evidence-Based Medicine, and Outcomes, 5) Resources of Support for Persons with Diabetes, 6) Drug Therapy, 7) Cardiovascular Risk Factors, 8) Acute Complications, 9) Chronic Complications, 10) Diabetes in Special Populations, and 11) Novel Therapeutic Approaches: Evidence-Based and Non-Proven, and Diabetes Prevention.


lt;p> Dr. Joel Rodriguez-Saldaña is a certified internist and diabetologist. He was Professor of Medicine at the National University of Mexico (UNAM) from 1980 to 2001 and was previously appointed to several professional positions in secondary and tertiary care hospitals in Mexico City. Since 1990, he has focused on developing and implementing outpatient diabetes management at public and private institutions, and in clinical practice. Since 1995 he has been associated with the International Diabetes Center in Minneapolis, where he has helped to implement Staged Diabetes Management, a structured program devoted to improving the quality of diabetes care. Dr. Rodriguez-Saldaña is a former Medical President of the Mexican Diabetes Federation and a current member of e.g. the American College of Physicians, American Heart Association, and American Association of Diabetes Educators. He has received 35 professional awards, including the first "Donell D. Etzwiler" award for achievements in diabetes care and citations from the Pan-American Health Organization and the American Association of Diabetes Educators. He has co-authored 11 textbooks on diabetes, and has published over 30 articles in Mexican and international peer-reviewed journals. Since 2003 he has been the General Director of REMEDI, an organization working to improve the quality of diabetes and chronic care management, continuing medical education, and clinical/pharmacologic research.

Preface: A New Disease?.- The Human Burden: Epidemiology of Diabetes across the World.- The Economic Burden: Direct and Indirect Costs of Diabetes.- The Global Burden of Diabetes.- The Ecological Approach to Self-Management in Diabetes.- Diabetes Outcomes and Social Determinants of Health.- Definition, Diagnostic Criteria, Screening, Diagnosis and Classification of Diabetes and Categories of Glucose Intolerance: an Update.- Homeostasis of Glucose and Intermediate Metabolism.- Pathophysiology of Type 1 Diabetes.- Pathophysiology of Type 2 Diabetes.- Genetic Determinants of Type 2 Diabetes.- Gene Expression Modifications in Type 2 Diabetes.- The Immune System and Inflammation in Type 2 Diabetes.- Dysfunction and Death of Pancreatic Beta Cells in Type 2 Diabetes.- Obesity in the Pathophysiology of Diabetes.- Pathogenesis of Gestational Diabetes.- Non-Alcoholic Fatty Liver in the Pathogenesis of Diabetes.- Microbiota in the Pathogenesis of Diabetes.- Diabetes and Circadian Rhythms.- Diabetes Management in Europe.- Diabetes Management in Asia.- Diabetes Management in the Americas.- Diabetes Management in the United States.- Diabetes Management in Mexico.- Diabetes Management in Africa.- Diabetes Management in Australia.- Evolution of the Patient-Centered Medical Home and Diabetes Care.- Outpatient Diabetes Management and the Chronic Care Model.- Clinical Practice Guidelines and Diabetes.- Evidence-Based Medicine and Diabetes: Contribution of Trials and Mega-Trials.- Measuring Diabetes Quality of Care: Clinical Outcomes, Cost-Effectiveness, and Patient Experience of Care.- Clinical Inertia and Diabetes Outcomes.- The Continuing Challenge of Patient Adherence.- Challenges and Scope of Diabetes Self-Care Education and Support.- Diabetes and Mental Health.- Tools of Self-Care: Self-Monitoring of Blood Glucose and Tele-Health Resources.- Continuous Glucose Monitoring in Clinical Practice: Ambulatory Glucose Profile and Advanced Glucose Sensing Technologies.- Type 2 Diabetes and Lifestyle Medicine.- Evidence and Implementation of Medical Nutrition Therapy in Persons with Diabetes.- Evidence and Implementation of Physical Activity and Exercise in Diabetes Management.- The "Old" Oral Antidiabetics.- Incretin Therapies: Current Use and Emerging Possibilities.- Sodium-Glucose Cotransporter 2 Inhibitors.- Use of Insulin in Outpatient Diabetes Management.- Insulin Pump Therapy.- Diabetes and Hypertension.- Diabetes and Atherogenic Dyslipidemia.- Obesity and Diabetes.- Metabolic and Bariatric Surgery in Diabetes Management.- Diabetes and Smoking: The Burden of Evidence.- Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperosmolar Non-Ketotic Status.- Hypoglycemia: Diagnosis, Management and Prevention.- Inpatient Management of Diabetes and Hyperglycemia.- Diabetes and Infection.- Biochemical Mechanisms of Vascular Complications in Diabetes.- Diabetes and Cardiovascular Disease.- Diabetes and Stroke: The Role of Glucose Regulation.- Peripheral Arterial Disease and Diabetes Mellitus.- Ophthalmic Disease in Diabetes.- Diabetes and Oral Health.- Renal Disease in Diabetes.- Peripheral Diabetic Neuropathies.- Diabetic Cardiac Autonomic Neuropathy.- Autonomic Visceral Neuropathy and Gastrointestinal Disorders.- Urologic Complications of Diabetes.- Musculoskeletal Complications of Diabetes.- Diabetes and the Skin.- Foot Complications.- Diabetes and Cancer.- Diabetes in Children and Adolescents.- Pregnancy: Pregestational and Gestational Management.- The Elderly with Diabetes.- The Artificial Pancreas.- Stem-Cell Therapy.- Immune-Regulating Interventions.- Unproven Therapies for Diabetes.- Diabetes Prevention.

Erscheint lt. Verlag 3.6.2023
Zusatzinfo XI, 1178 p. 18 illus. In 2 volumes, not available separately.
Verlagsort Cham
Sprache englisch
Maße 210 x 279 mm
Gewicht 3960 g
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete
Studium Querschnittsbereiche Prävention / Gesundheitsförderung
Schlagworte Acute complications • Chronic complications • Diabetes • Medical Care • pathophysiology • prevention • Public Health
ISBN-10 3-031-25518-6 / 3031255186
ISBN-13 978-3-031-25518-2 / 9783031255182
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?